Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer's disease

被引：13

作者：

Wei, Li-Li ^{[1
]}

Shen, Yue-Di ^{[2
]}

Zhang, Ying-Chun ^{[1
]}

Hu, Xing-Yue ^{[3
]}

Lu, Pei-Ling ^{[3
]}

Wang, Li ^{[3
]}

Chen, Wei ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Dept Mental Hlth, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China

[2] Hangzhou Normal Univ, Sch Med, Dept Diagnost, Affiliated Hosp, Hangzhou 310015, Zhejiang, Peoples R China

[3] Zhejiang Univ, Sch Med, Dept Neurol, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China

来源：

NEUROSCIENCE BULLETIN | 2010年 / 26卷 / 01期

关键词：

inflammation; Alzheimer's disease; prostaglandin E-2; prostaglandin E-2 receptors; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CEREBRAL-ISCHEMIA; MICROGLIAL ACTIVATION; PROSTANOID RECEPTORS; SIGNALING PATHWAY; NEURONAL SURVIVAL; BETA PHAGOCYTOSIS; CORTICAL-NEURONS; OXIDATIVE DAMAGE; INNATE IMMUNITY;

D O I：

10.1007/s12264-010-0703-z

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Neuroinflammation has always been of concern in the pathogenesis of Alzheimer's disease (AD). As a major inflammatory mediator, prostaglandin E-2 (PGE(2)) plays an important role in the inflammatory process of AD. Up to now, there is still controversy on the neuroprotective or neurotoxic role of PGE(2). However, the role of PGE(2) in neurodegeneration may be far more complex, due to the 4 EP receptor subtypes. This article aims to summarize the relationship between PGE(2) receptor EP subtypes and AD. It is believed that a better understanding of the PGE(2) receptor EP subtypes may help to clarify the relation between inflammation and AD, and to develop novel therapeutic strategies targeting specific EP receptor for AD treatment.

引用

页码：77 / 84

页数：8

共 50 条

[1] Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer’s disease前列腺素E2 受体EP 亚型在阿尔茨海默病中的作用
Li-Li Wei
Yue-Di Shen
Ying-Chun Zhang
Xing-Yue Hu
Pei-Ling Lu
Li Wang
Wei Chen
[J]. Neuroscience Bulletin, 2010, 26 : 77 - 84
[2] Prostaglandin E2 EP receptors in cardiovascular disease: An update
Bryson, Timothy D.
Harding, Pamela
[J]. BIOCHEMICAL PHARMACOLOGY, 2022, 195
[3] Distinct Roles of Central and Peripheral Prostaglandin E2 and EP Subtypes in Blood Pressure Regulation
Yang, Tianxin
Du, Yaomin
[J]. AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (10) : 1042 - 1049
[4] Prostaglandin E2 as a mediator of fever:: The role of prostaglandin (EP) receptors
Oka, T
[J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3046 - 3057
[5] Gastric Cytoprotection by prostaglandin E2 -: Relation to EP receptor subtypes
Takeuchi, K
Kato, S
Komoike, Y
Ogawa, Y
Takeeda, M
[J]. MECHANISMS AND CONSEQUENCES OF PROTON TRANSPORT, 2002, : 169 - 180
[6] Regulation of prostaglandin E2 receptors (EP) in glial cells
Waschbisch, A
Hüll, M
Fiebich, BL
[J]. GLIA, 2002, : S63 - S63
[7] Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract
Takeuchi, Koji
Amagase, Kikuko
[J]. CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (18) : 2002 - 2011
[8] The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach
Araki, H
Ukawa, H
Sugawa, Y
Yagi, K
Suzuki, K
Takeuchi, K
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 : 116 - 124
[9] The role of the EP receptors for prostaglandin E2 in skin and skin cancer
J. E. Rundhaug
M. S. Simper
I. Surh
S. M. Fischer
[J]. Cancer and Metastasis Reviews, 2011, 30 : 465 - 480
[10] Prostaglandin E2 EP receptors as therapeutic targets in breast cancer
Jocelyn Reader
Dawn Holt
Amy Fulton
[J]. Cancer and Metastasis Reviews, 2011, 30 : 449 - 463

← 1 2 3 4 5 →